Method of treating hyperprolactinemia and prolactinomas
US5972893A · kind A · utility
3Cited by
2References
44Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1997 |
| Grant date | Oct 26, 1999 |
| Priority date | — |
| Expiry date | May 6, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating hyperprolactinemia in an animal, including a human, administers one or more somatostatin type-5 receptor agonist(s) to, for example, lower abnormally high levels of prolactin in the blood of the animal. A method of treating a subject, including a human, afflicted by a prolactinoma, administers one or more type-5 receptor selective agonist(s) to, for example, lower prolactin secretion and/or decrease tumor size in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.